Angiodynamics (ANGO) Accounts Payables (2011 - 2026)

Angiodynamics has reported Accounts Payables for 16 years, with the latest figure at $29.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 3.83% year-over-year to $29.1 million; the trailing twelve-month figure through Feb 2026 stood at $29.1 million (down 3.83% YoY), and the FY2025 full-year result was $33.3 million, down 11.81% from the prior year.
• Accounts Payables for Q1 2026 stood at $29.1 million, down from $35.4 million in the prior quarter.
• The five-year high for Accounts Payables was $40.4 million in Q2 2023, with the low at $21.6 million in Q1 2022.
• Historically, Accounts Payables has averaged $32.4 million across 5 years, with a median of $33.3 million in 2025.
• The largest YoY upside for Accounts Payables was 65.04% in 2023 against a maximum downside of 15.21% in 2023.
• Angiodynamics' Accounts Payables stood at $34.7 million in 2022, then grew by 8.54% to $37.6 million in 2023, then declined by 7.71% to $34.7 million in 2024, then increased by 1.85% to $35.4 million in 2025, then fell by 17.76% to $29.1 million in 2026.
• The last three Accounts Payables figures came in at $29.1 million (Q1 2026), $35.4 million (Q4 2025), and $31.9 million (Q3 2025), per Business Quant data.